Robotics startup Genrobotics saw its operating revenue rise 35% to ₹43.7 Cr in FY26 from ₹32.5 Cr in the previous fiscal, cofounder and CEO Vimal Govind MK told Inc42.
The startup’s profit after tax (PAT) nearly tripled to ₹2.6 Cr in FY26 from ₹90 Lakh a year ago. Meanwhile, EBITDA jumped 74% to ₹6.6 Cr from ₹3.8 Cr, with EBITDA margin expanding to 15.2% from 11.6%. PAT margin also improved to 6% from 2.8%.
Now, Genrobotics is looking to accelerate the adoption of its robotic solutions designed to eliminate hazardous human labour. The Thiruvananthapuram-based startup is eyeing over 5X YoY growth in revenue to ₹219.9 Cr in FY27, with EBITDA and PAT estimated to rise to ₹67.2 Cr and ₹42.7 Cr, respectively.
CEO Govind attributed the projected growth to stronger product-market fit across its core verticals and improving business-market fit. Competitive pricing, wider market penetration and stronger manufacturing capabilities are expected to drive the startup’s next phase of growth, Govind added.
Founded in 2017 by Govind MK, Arun George, Nikhil NP and Rashid K, Genrobotics builds robots for jobs that are dangerous, physically demanding or difficult for humans to perform. Its best-known product, Bandicoot, automates manhole and sewer cleaning, reducing the need for workers to enter confined spaces.
After starting with sanitation, the startup has expanded into medical robotics, oil and gas, and more recently, defence and space technology. In medical robotics, Genrobotics develops rehabilitation systems for patients affected by strokes, spinal cord injuries and Parkinson’s disease.
Its G-Gait robotic exoskeleton supports gait training by guiding patients through repeated walking movements, while its upper-body systems are designed to help restore movements required for everyday activities.
On the defence front, Genrobotics is developing autonomous rovers for reconnaissance and hazard neutralisation in hostile terrains. In spacetech, it is building robotic arms for space debris removal and on-orbit satellite servicing, including inspection, repair and refuelling.
Genrobotics Eyes ₹150 Cr Funding
The startup is now looking to raise ₹150 Cr in a Series B round in the ongoing fiscal year, after raising more than ₹100 Cr, including debt, to date. It is in talks with domestic and international investors for the funding round, the CEO said, without disclosing the names of the investors.
“My focus is on expanding our production centres because we need more manufacturing capacity. This year, we have a ₹155 Cr revenue pipeline, of which nearly ₹100 Cr is already booked through tenders, purchase orders and other contracts,” Govind said.
The startup plans to deploy around 80-90% of the fresh capital towards expanding production capacity, while a portion will be used to deepen its international presence.
Genrobotics currently has about 30,000 sq ft of manufacturing capacity across Kerala and Andhra Pradesh, including a 5,000 sq ft medical robotics unit at the Andhra Pradesh MedTech Zone (AMTZ). It is also looking to set up a manufacturing unit in Uttar Pradesh and Hyderabad in the coming months.
A new facility in Kerala is expected to double its manufacturing footprint to 60,000 sq ft. Over the next five years, the startup aims to expand its manufacturing footprint to 5 Lakh sq ft as it targets ₹1,600 Cr in annual revenue.
The startup counts Zoho, Unicorn India Ventures, Peak XV Partners and prominent business leader Anand Mahindra among its investors.
The Road Ahead For Genrobotics
Currently, Genrobotics is developing robotic arms for space debris collection and satellite maintenance. Its emerging portfolio includes G-Bot, a bipedal robot, and GenBot, a semi-humanoid system. It is also targeting an indigenous bipedal-walking demonstration by the end of FY27.
The startup plans to remain focused on its four existing verticals. Sanitation currently accounts for about 60% of Genrobotics’ revenue, with medical robotics contributing the remaining 40%. Its defence and space businesses are currently at an early stage.
“Sanitation is going to drive the majority of our revenue. It has taken time because government adoption requires pilots and validation, but once trust is established, the scale comes rapidly,” Govind said.
The CEO said that the startup has filed more than 30 patents and built a portfolio of over 20 intellectual properties, with 10 granted in India and overseas markets, including South Africa and Singapore.
Genrobotics is now looking to expand its patent portfolio in the US as it scales its medical robotics business there. The startup has begun building a team for the US market after gaining clients in South Korea and other overseas markets.
In March this year, Genrobotics secured an ₹80 Cr contract from Singapore’s national water agency, PUB, to deploy nearly 44 robots across the country’s water infrastructure. The startup plans to deploy its Wilboar robots, used for remote and fully robotic cleaning of tunnels, ducts, and pipelines with zero manual entry in refinery and chemical plants, over the next two financial years.
Last month, Genrobotics also led a ₹1 Cr seed funding round in Estro Tech Robotics, a robotics and AIoT solutions startup.
The startup operates in India’s rapidly growing industrial robotics market, which is projected to grow to $1.55 Bn by 2030.
The post Zoho-Backed Genrobotics Posts ₹2.6 Cr Profit In FY26, Eyes ₹150 Cr Series B Round appeared first on Inc42 Media.
https://ift.tt/Wx1tLql
0 Comments